Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Microbiology Spectrum|October 13, 2021
Comparative Performance of a New SARS-CoV-2 Rapid Detection SystemGianni Gori Savellini, Gabriele Anichini, Chiara Terrosi, et al.Pathogens (Basel, Switzerland)|March 26, 2022
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access BloodstreamClaudia Gandolfo, Chiara Terrosi, Shibily Prathyumnan, et al.Viruses|March 30, 2023
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVIDMaria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, et al.Pathogens (Basel, Switzerland)|December 28, 2021
Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED LightChiara Terrosi, Gabriele Anichini, Jean Denis Docquier, et al.Vaccines|May 28, 2022
Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in VaccineesGabriele Anichini, Chiara Terrosi, Claudia Gandolfo, et al.Journal of Medical Virology|December 26, 2024
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring ImmunityGabriele Anichini, Chiara Terrosi, Giulia Alessandri, et al.Journal of Medical Virology|January 11, 2021
Antibody response to SARS-CoV-2 in infected patients with different clinical outcomeGabriele Anichini, Claudia Gandolfo, Chiara Terrosi, et al.Science Immunology|August 9, 2024
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlinesIda Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.Vaccines|February 26, 2022
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA VaccineClaudia Gandolfo, Gabriele Anichini, Marco Mugnaini, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccinesAnna M Di Giacomo, Gianluca Giacobini, Gabriele Anichini, et al.Pageof 3